Electra Therapeutics, Inc. Common stock (ETRA) stock: key figures, P/E, revenue and dividend
Health Care · United States
Electra Therapeutics, Inc. Common stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Operating income | -26.32 m USD | -61.89 m USD |
| EBIT | -24.79 m USD | -60.54 m USD |
| Net income | -24.79 m USD | -61.98 m USD |
| Diluted EPS – continuing operations | -0.39 USD | -0.99 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Electra Therapeutics, Inc. Common stock
Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, enabling medical professionals to find an approved treatment for secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition. The company was incorporated in 2018 and is based in South San Francisco, California.
More stocks
- ACCO BRANDS Corp (ACCO)
- China Steel Chemical Corp (1723.TW)
- Valneva SE (VLA.PA)
- Sijin Intelligent Forming Machinery (003025.SZ)
- Tinc NV (TINC.BR)
- ZheJiang Haers Vacuum Containers Co Ltd (002615.SZ)
- Shanghai National Center of Testing and Inspection for Electric Cable and Wire Co. Ltd. (301289.SZ)
- ANGIODYNAMICS INC (ANGO)
- OOMA INC (OOMA)
- Grupo Supervielle SA (SUPV)
- Flytech Technology Co Ltd (6206.TW)
- Smartgiant Technology Co. Ltd. A (688115.SS)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.